BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 28721444)

  • 1. Neovascular glaucoma after proton beam therapy of choroidal melanoma: incidence and risk factors.
    Riechardt AI; Pilger D; Cordini D; Seibel I; Gundlach E; Hager A; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2263-2269. PubMed ID: 28721444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters.
    Mishra KK; Daftari IK; Weinberg V; Cole T; Quivey JM; Castro JR; Phillips TL; Char DH
    Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):330-6. PubMed ID: 23886415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Side effects of proton beam therapy of choroidal melanoma in dependence of the dose to the optic disc and the irradiated length of the optic nerve.
    Riechardt AI; Stroux A; Seibel I; Heufelder J; Zeitz O; Böhmer D; Joussen AM; Gollrad J
    Graefes Arch Clin Exp Ophthalmol; 2020 Nov; 258(11):2523-2533. PubMed ID: 32533280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choroidal melanoma: does endoresection prevent neovascular glaucoma in patient treated with proton beam irradiation?
    Cassoux N; Cayette S; Plancher C; Lumbroso-Le Rouic L; Levy-Gabriel C; Asselain B; Sastre X; Couturier J; Arrufat S; Piperno-Neumann S; Dendale R; Lehoang P; Desjardins L
    Retina; 2013; 33(7):1441-7. PubMed ID: 23514798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton beam therapy of parapapillary choroidal melanoma.
    Riechardt AI; Cordini D; Willerding GD; Georgieva I; Weber A; Seibel I; Lakotka N; Bechrakis NE; Foerster MH; Moser L; Joussen AM
    Am J Ophthalmol; 2014 Jun; 157(6):1258-65. PubMed ID: 24548873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for neovascular glaucoma after carbon ion radiotherapy of choroidal melanoma using dose-volume histogram analysis.
    Hirasawa N; Tsuji H; Ishikawa H; Koyama-Ito H; Kamada T; Mizoe JE; Ito Y; Naganawa S; Ohnishi Y; Tsujii H
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):538-43. PubMed ID: 17141971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trans-scleral local resection of toxic choroidal melanoma after proton beam radiotherapy.
    Konstantinidis L; Groenewald C; Coupland SE; Damato B
    Br J Ophthalmol; 2014 Jun; 98(6):775-9. PubMed ID: 24568869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy.
    Mahdjoubi A; Najean M; Lemaitre S; Dureau S; Dendale R; Levy C; Rouic LL; Desjardins L; Cassoux N
    Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):411-420. PubMed ID: 29116399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of carbon ion radiation therapy for locally advanced or unfavorably located choroidal melanoma: usefulness of CT-based 2-port orthogonal therapy for reducing the incidence of neovascular glaucoma.
    Toyama S; Tsuji H; Mizoguchi N; Nomiya T; Kamada T; Tokumaru S; Mizota A; Ohnishi Y; Tsujii H;
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):270-6. PubMed ID: 23414768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage proton beam therapy for recurrent iris melanoma: outcome and side effects.
    Riechardt AI; Klein JP; Cordini D; Heufelder J; Rehak M; Seibel I; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2018 Jul; 256(7):1325-1332. PubMed ID: 29464331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton therapy of iris melanoma with 50 CGE : Influence of target volume on clinical outcome.
    Riechardt AI; Karle B; Cordini D; Heufelder J; Budach V; Joussen AM; Gollrad J
    Strahlenther Onkol; 2017 Nov; 193(11):943-950. PubMed ID: 28631017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal bevacizumab for iris neovascularization following proton beam irradiation for choroidal melanoma.
    Yeung SN; Paton KE; Waite C; Maberley DA
    Can J Ophthalmol; 2010 Jun; 45(3):269-73. PubMed ID: 20379286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes After Proton Beam Therapy for Large Choroidal Melanomas in 492 Patients.
    Bensoussan E; Thariat J; Maschi C; Delas J; Schouver ED; Hérault J; Baillif S; Caujolle JP
    Am J Ophthalmol; 2016 May; 165():78-87. PubMed ID: 26940166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of Proton Beam Therapy for Ocular Melanoma Using a Novel 3D Treatment Planning Technique.
    Hartsell WF; Kapur R; Hartsell SO; Sweeney P; Lopes C; Duggal A; Cohen J; Chang J; Polasani RS; Dunn M; Pankuch M
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):353-359. PubMed ID: 27084652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term Outcomes After Proton Beam Irradiation in Patients With Large Choroidal Melanomas.
    Papakostas TD; Lane AM; Morrison M; Gragoudas ES; Kim IK
    JAMA Ophthalmol; 2017 Nov; 135(11):1191-1196. PubMed ID: 29049518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant Ab Interno Tumor Treatment After Proton Beam Irradiation.
    Seibel I; Riechardt AI; Heufelder J; Cordini D; Joussen AM
    Am J Ophthalmol; 2017 Jun; 178():94-100. PubMed ID: 28365241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma.
    Seibel I; Cordini D; Hager A; Tillner J; Riechardt AI; Heufelder J; Davids AM; Rehak M; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1787-92. PubMed ID: 27376824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-Response and Normal Tissue Complication Probabilities after Proton Therapy for Choroidal Melanoma.
    Espensen CA; Kiilgaard JF; Appelt AL; Fog LS; Herault J; Maschi C; Caujolle JP; Thariat J
    Ophthalmology; 2021 Jan; 128(1):152-161. PubMed ID: 32574763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual Outcomes after Proton Beam Irradiation for Choroidal Melanomas Involving the Fovea.
    Patel AV; Lane AM; Morrison MA; Trofimov AV; Shih HA; Gragoudas ES; Kim IK
    Ophthalmology; 2016 Feb; 123(2):369-377. PubMed ID: 26545316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of radiation retinopathy after beam proton irradiation in centrally located choroidal melanoma.
    Busch C; Löwen J; Pilger D; Seibel I; Heufelder J; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1599-1604. PubMed ID: 29948179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.